These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 2142096)
1. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Dreteler GH; Wouters W; Saxena PR Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis. Fozard JR; Mir AK; Middlemiss DN J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400 [TBL] [Abstract][Full Text] [Related]
3. Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat. Dreteler GH; Wouters W; Toorop GP; Jansen JA; Saxena PR J Cardiovasc Pharmacol; 1991 Mar; 17(3):488-93. PubMed ID: 1711612 [TBL] [Abstract][Full Text] [Related]
4. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats. Buisson-Defferier S; Hibert M; van den Buuse M Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241 [TBL] [Abstract][Full Text] [Related]
5. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. Gradin K; Pettersson A; Hedner T; Persson B J Neural Transm; 1985; 62(3-4):305-19. PubMed ID: 3161997 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the 5-HT1A receptor ligand, MDL 73005EF, in conscious spontaneously hypertensive rats. Buisson-Defferier S; Van den Buuse M Eur J Pharmacol; 1992 Nov; 223(2-3):133-41. PubMed ID: 1362161 [TBL] [Abstract][Full Text] [Related]
7. Contractile effects of 8-hydroxy-2-(di-n-propylamino)tetralin and flesinoxan in human isolated basilar artery. Parsons AA; Motevalian M; Whalley ET Eur J Pharmacol; 1991 Sep; 202(1):17-23. PubMed ID: 1664803 [TBL] [Abstract][Full Text] [Related]
8. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity. Millan MJ; Bervoets K; Colpaert FC J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033 [TBL] [Abstract][Full Text] [Related]
9. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors. Clarke RW; Ogilvie J; Houghton AK Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958 [TBL] [Abstract][Full Text] [Related]
11. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats. Bouhelal R; Loubatières-Mariani MM; Mir AK Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614 [TBL] [Abstract][Full Text] [Related]
12. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors. Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650 [TBL] [Abstract][Full Text] [Related]
13. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat. Bervoets K; Millan MJ; Colpaert FC Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818 [TBL] [Abstract][Full Text] [Related]
14. Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat. Dreteler GH; Wouters W; Saxena PR J Cardiovasc Pharmacol; 1989 Nov; 14(5):770-6. PubMed ID: 2481192 [TBL] [Abstract][Full Text] [Related]
15. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats. Martin GE; Lis EV Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366 [TBL] [Abstract][Full Text] [Related]
16. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Goodwin GM; Green AR Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats. Connor HE; Higgins GA Eur J Pharmacol; 1990 Jun; 182(1):63-72. PubMed ID: 2144824 [TBL] [Abstract][Full Text] [Related]
18. 8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits. Hof RP; Fozard JR Br J Pharmacol; 1989 Apr; 96(4):864-71. PubMed ID: 2568144 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects following injection of 8-OH-DPAT and flesinoxan into the dorsal raphe nucleus of conscious rats. Connor HE; Higgins GA Br J Pharmacol; 1989 Dec; 98 Suppl():810P. PubMed ID: 2532943 [No Abstract] [Full Text] [Related]
20. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks. Millan MJ; Bervoets K; Colpaert FC Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]